Download presentation
Presentation is loading. Please wait.
1
European Journal of Cancer
Quality measures of the population-based Finnish Cancer Registry indicate sound data quality for solid malignant tumours Maarit K. Leinonen, Joonas Miettinen, Sanna Heikkinen, Janne Pitkäniemi, Nea Malila European Journal of Cancer Volume 77, Pages (May 2017) DOI: /j.ejca Copyright © 2017 Elsevier Ltd Terms and Conditions
2
Fig. 1 The international standards of classification and coding of neoplasms used in the Finnish Cancer Registry 1953–2013. European Journal of Cancer , 31-39DOI: ( /j.ejca ) Copyright © 2017 Elsevier Ltd Terms and Conditions
3
Fig. 2 Proportion of incident cancers that were registered with uncertain primary site (PSU%) in Finland in 2009–2013 by age group and gender. European Journal of Cancer , 31-39DOI: ( /j.ejca ) Copyright © 2017 Elsevier Ltd Terms and Conditions
4
Fig. 3 (A) Annual trends in age-standardised (world) incidence rates for all sites and for selected sites in women. (B) Annual trends in age-standardised (world) incidence rates for all sites and for selected sites in men, Finland 1953–2013. European Journal of Cancer , 31-39DOI: ( /j.ejca ) Copyright © 2017 Elsevier Ltd Terms and Conditions
5
Fig. 4 (A) Mortality:incidence ratios versus 1-survival for all sites and for 15 most common sites for Finnish women. (B) Mortality:incidence ratios versus 1-survival for all sites and for 15 most common sites for Finnish men, 2009–2013. European Journal of Cancer , 31-39DOI: ( /j.ejca ) Copyright © 2017 Elsevier Ltd Terms and Conditions
6
Fig. A.1 Comparison of mortality: incidence ratios by cancer sites in Nordic countries for women in 2009–2013. European Journal of Cancer , 31-39DOI: ( /j.ejca ) Copyright © 2017 Elsevier Ltd Terms and Conditions
7
Fig. A.2 Comparison of mortality: incidence ratios by cancer sites in Nordic countries for men in 2009–2013. European Journal of Cancer , 31-39DOI: ( /j.ejca ) Copyright © 2017 Elsevier Ltd Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.